Ocuphire Pharma, Inc. Insider Trading for January 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Ocuphire Pharma, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Ocuphire Pharma, Inc. for January 2018.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 30 2018 | RNN | REXAHN PHARMACEUTI ... | Suzdak Peter David | Chief Executive Off ... | Option Exercise | A | 2.29 | 112,271 | 257,101 | 112,271 | |
| Jan 30 2018 | RNN | REXAHN PHARMACEUTI ... | Nolan Lisa | Chief Business Offi ... | Option Exercise | A | 2.29 | 42,101 | 96,411 | 42,101 | |
| Jan 30 2018 | RNN | REXAHN PHARMACEUTI ... | Benaim Ely | Chief Medical Offic ... | Option Exercise | A | 2.29 | 45,443 | 104,064 | 45,443 | |
| Jan 04 2018 | RNN | REXAHN PHARMACEUTI ... | Swirsky Douglas J | President and CFO | Option Exercise | A | 2.10 | 250,000 | 525,000 | 250,000 |